Scalable Capital is valued in excess of $460m following a Tengelmann-backed round that lifted the digital wealth manager’s total funding to about $130m.
Month: July 2020
4D Molecular forgoes IPO option
Pfizer and Chiesi-backed genetic drug developer 4DMT has pulled away from a proposed $100m offering after closing series C funding last month.
CreatorIQ cracks series C with $24m
Existing investor Unilever Ventures returned for the marketing management platform developer’s latest round, following its series B a year ago.
Vesigen spawns with series A funding
Leaps by Bayer has co-led a $28.5m series A round disclosed when precision medicine startup Vesigen Therapeutics publicly launched.
CurvaFix gets series B implant
Delta Dental Washington Seed Fund was among the participants in a $10.8m round for the pelvic bone implant developer.
Working together to improve the ecosystem
There is an old rule of thumb that service providers in a market improve its efficiency by about five-fold.
Xingsheng Youxuan to ring up $800m
The grocery e-commerce platform is set to raise the cash in a Tencent-backed series C-plus round, just weeks after it reportedly lined up $300m in series C financing.
Innovium inserts $170m
The data centre technology provider boosted its overall funding to approximately $335m with a round that included long-term investor Qualcomm Ventures.
Hippo tips in another $150m
The online home insurer is valued at $1.5bn after a series E round backed by Standard Industries, Lennar, Comcast Ventures and Propel Venture Partners.
Cerevance steps up series B to $65m
The CNS disease therapy developer raised a further $20m, adding to a $45m close in April that included GV and Takeda Ventures.
CIM Group sees out $40m Ecoppia investment
The real estate investment manager is now the largest investor in Harel Group-backed Ecoppia, which provides solar-panel cleaning systems.
Taranis takes in $30m
Kuok Group co-led a $30m round for the crop-monitoring system developer that also attracted Hitachi and Micron Technology, to more than double its total funding.
XpectVision scans series B-plus funding
Septwolves Ventures participated in a $21.5m round for the X-ray equipment producer that was led by a China Construction Bank fund.
T3 Pharma treats itself to more funding
Boehringer Ingelheim Venture Fund followed an investment last September by contributing to a $26.8m round for the bacteria-based cancer drug developer.